Robert Johnston

TL;DR: In this paper, the authors provide a clinicopathological report of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases by documenting histopathological changes and evidence of SARS CoV2 tissue tropism.

TL;DR: A clinicopathological report of severe COVID-19 cases by documenting histopathological changes and evidence of SARS-CoV-2 tissue tropism is provided.

TL;DR: SARS-CoV-2 represents the third novel coronavirus to cause widespread human disease since 2002, and the primary pathology was diffuse alveolar damage with virus located in the pneumocytes, however, other major organs including the heart and kidneys may be susceptible to viral replication and damage leading to increased mortality in those with disseminated disease.

TL;DR: Tiragolumab + atezolizumab (anti-PD-L1) combination treatment demonstrated significant improvement relative to TIGIT alone in non-small cell lung cancer (NSCLC) as mentioned in this paper .

TL;DR: In this paper , the authors investigated TLR9 activation as a potential mechanism of resistance to current B-cell receptor (BCR)-targeted therapeutics and found that TLR 9 activation induced a dichotomous migratory response in CLL patient samples.